RxDoctor Payments Data

Theresa Fortaleza Dawson, MD

Geriatric Medicine · Ft Lauderdale, FLNPI 1871507780

Payments from drug & device makers

$149in general payments, 2019–2025

Across 8 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$64
  • GSK$23
  • Esperion Therapeutics, Inc.$19
  • Insmed, Inc.$16
  • Sobi, Inc$15
  • Linus Health, Inc.$13

What the payments were for

  • Food & beverage$149100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Otsuka America Pharmaceutical, Inc.3$64
GSK1$23
Esperion Therapeutics, Inc.1$19
Insmed, Inc.1$16
Sobi, Inc1$15
Linus Health, Inc.1$13

How this compares

$149 in reported general payments places this provider in the 30th percentile of 305 geriatric medicine providers in Florida.

See all geriatric medicine providers in Florida

Medicare billing

Part B allowed, 2024
$344,397
Medicare patients
358
Services billed
3,402

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban107$95,081
Trelegy ElliptaFluticasone/Umeclidin/Vilanter68$56,343
JanuviaSitagliptin Phosphate53$47,603
TrulicityDulaglutide22$22,244
EntrestoSacubitril/Valsartan17$21,240
FarxigaDapagliflozin Propanediol19$20,370
XareltoRivaroxaban14$17,197
JardianceEmpagliflozin14$12,892
OzempicSemaglutide15$12,035
MyrbetriqMirabegron11$11,055
NexlizetBempedoic Acid/Ezetimibe14$10,117
VascepaIcosapent Ethyl16$8,100
Celecoxib73$6,182
Memantine Hcl33$3,670
Metoprolol Succinate199$3,040

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$23$56,34368 claims
Esperion Therapeutics, Inc.Nexlizet$19$10,11714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 305 geriatric medicine providers in Florida.

Other geriatric medicine in Ft Lauderdale

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →